Subscribe
shutterstock_1725090718_michael_vi
Michael Vi / Shutterstock.com
6 April 2021MedtechAlex Baldwin

Moldex-Metric hits Honeywell with false advertising suit

Honeywell has been targeted in a recent complaint from competitor Moldex-Metric over a newly-launched “antimicrobial” earplug dispenser, which Moldex claims is falsely advertised.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
CBD retailer sues over rival’s ‘false, disparaging’ TM use
15 February 2021   Cannabidiol retailer cbdMD is suing rival Majik Medicine over the latter’s use of the ‘CBD MD’ trademark, claiming it is confusing consumers.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

More on this story

Americas
CBD retailer sues over rival’s ‘false, disparaging’ TM use
15 February 2021   Cannabidiol retailer cbdMD is suing rival Majik Medicine over the latter’s use of the ‘CBD MD’ trademark, claiming it is confusing consumers.

More on this story

Americas
CBD retailer sues over rival’s ‘false, disparaging’ TM use
15 February 2021   Cannabidiol retailer cbdMD is suing rival Majik Medicine over the latter’s use of the ‘CBD MD’ trademark, claiming it is confusing consumers.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent